The Californian biopharma company will hire for positions across clinical development, supply chain, IT, facilities and engineering and more.
Gilead Sciences, the biopharmaceutical company led out of California, has announced this morning (8 July) that it will expand its Irish operations in Cork and Dublin.
The company is hiring for roles across clinical development, process development, analytical operations, legal, HR, supply chain, IT, facilities, engineering and financial shared services. Recruitment will take place over the next two years with a view to filling the jobs by early 2022.
Gilead’s manufacturing facilities have been operating in Ireland for 20 years, supplying countries across Europe and other international locations outside of the US. Its Irish sites include a drug product manufacturing and packing facility in Carrigtwohill, Co Cork and a financial shared services centre in Little Island, Co Cork that supports Gilead affiliates in Europe, the Middle East, Asia and South America. A distribution centre in Dublin distributes to 90 markets worldwide.
Currently employing 370 full-time staff and an additional 119 contingent workers, the company is looking for a location for its new Dublin office. Dublin will house the majority of the new jobs, with the rest opening up in Cork.
Tánaiste and Minister for Enterprise, Trade & Employment Leo Varadkar, TD, spoke about the company’s commitment to Ireland: “Gilead has been steadily growing its presence here over the last 20 years and today’s announcement underlines the company’s commitment to Ireland.
“This expansion shows that Ireland offers the right conditions – particularly our skilled and talented workforce – to allow companies like Gilead to grow their operations here. I wish them well in this next exciting chapter.”
Gilead’s vice-president of manufacturing operations and its general manager in Ireland David Cadogan said: “Gilead has a long record of operating in Ireland and our teams here have played a critical role in ensuring that patients in Europe and other parts of the world outside of the US have access to our medicines.
“With this additional investment, we are looking forward to continuing this important work and growing our presence here in Ireland.”
Gilead’s expansion is supported by IDA Ireland. Its CEO, Martin Shanahan, described Gilead’s expansion as “really positive news from the pharmaceutical industry in Ireland”, demonstrating a “huge vote of confidence in Ireland and our strong value proposition”.
To learn more about vacancies at Gilead, visit its careers portal here.
